mechlorethamine has been researched along with Lymphoma in 241 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aims of this study were to evaluate the safety of mustargen, vincristine, procarbazine and prednisone (MOPP) chemotherapy in the treatment of relapsed or refractory feline lymphoma, and to determine the overall response rate and median remission time with this protocol." | 7.96 | Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats. ( Brown, DC; Krick, EL; MaloneyHuss, MA; Mauldin, GE; Veluvolu, SM, 2020) |
| "Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival." | 7.88 | Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 7.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Forty-one dogs with resistant lymphoma were treated with a modified MOPP (mechlorethamine, vincristine, procarbazine and prednisone) protocol (MPP [mechlorethamine, procarbazine and prednisone] administered on a 21-day cycle, shortened from the 28-day MOPP cycle)." | 7.75 | Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. ( Childress, MO; Gieger, TL; Hume, KR; Keys, DA; Kosarek, CE; LeRoy, BE; Northrup, NC; Saba, CF; Wall, TM, 2009) |
| "To study the exact frequency and the histological features of cutaneous intolerance to mechlorethamine (CIM) hydrochloride therapy in patients with cutaneous T-cell lymphomas, including Langerhans cell histiocytosis." | 7.70 | A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas. ( Avril, MF; Bagot, M; Beylot-Barry, M; Delaunay, M; Estève, E; Grange, F; Joly, P; Laroche, L; Souteyrand, P; Thomine, E; Vaillant, L; Wechsler, J, 1999) |
| "Complete responses lasting from 4 to 14 years were documented in 65 of 331 (20%) patients with cutaneous T cell lymphoma treated with topical mechlorethamine (HN2) between 1968 and 1982." | 7.67 | Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. ( Kantor, AF; Micaily, B; Shrager, L; Tan, ET; Van Scott, EJ; Vonderheid, EC, 1989) |
| "Sixty-seven evaluable patients with mixed cellular and histiocytic lymphomas, both nodular and diffuse, were treated with a combined drug regimen of BCNU, cyclophosphamide, vincristine, and prednisone administered for six monthly courses." | 7.65 | 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma. ( Chan, YK; Dorfman, R; Durant, JR; Loeb, V, 1975) |
| " The risk of treatment-induced acute leukemias as well as sterility can be avoided or greatly decreased with drug combinations not including procarbazine HCI and alkylating agents." | 4.77 | Chemotherapy of malignant lymphomas. ( Bonadonna, G, 1985) |
| "The aims of this study were to evaluate the safety of mustargen, vincristine, procarbazine and prednisone (MOPP) chemotherapy in the treatment of relapsed or refractory feline lymphoma, and to determine the overall response rate and median remission time with this protocol." | 3.96 | Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats. ( Brown, DC; Krick, EL; MaloneyHuss, MA; Mauldin, GE; Veluvolu, SM, 2020) |
| "Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival." | 3.88 | Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 3.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Forty-one dogs with resistant lymphoma were treated with a modified MOPP (mechlorethamine, vincristine, procarbazine and prednisone) protocol (MPP [mechlorethamine, procarbazine and prednisone] administered on a 21-day cycle, shortened from the 28-day MOPP cycle)." | 3.75 | Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. ( Childress, MO; Gieger, TL; Hume, KR; Keys, DA; Kosarek, CE; LeRoy, BE; Northrup, NC; Saba, CF; Wall, TM, 2009) |
| "To study the exact frequency and the histological features of cutaneous intolerance to mechlorethamine (CIM) hydrochloride therapy in patients with cutaneous T-cell lymphomas, including Langerhans cell histiocytosis." | 3.70 | A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas. ( Avril, MF; Bagot, M; Beylot-Barry, M; Delaunay, M; Estève, E; Grange, F; Joly, P; Laroche, L; Souteyrand, P; Thomine, E; Vaillant, L; Wechsler, J, 1999) |
| "We investigated the temporal regulation of cyclin A- and B1-dependent kinases in human lymphoma cells treated with nitrogen mustard (HN2) and pentoxifylline, to determine whether the activity of these complexes correlated with cell cycle arrest induced by DNA damage." | 3.68 | G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. ( Draetta, G; Ferris, DK; Hunter, T; Kohn, KW; Longo, DL; O'Connor, PM; Pagano, M; Pines, J, 1993) |
| "Complete responses lasting from 4 to 14 years were documented in 65 of 331 (20%) patients with cutaneous T cell lymphoma treated with topical mechlorethamine (HN2) between 1968 and 1982." | 3.67 | Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. ( Kantor, AF; Micaily, B; Shrager, L; Tan, ET; Van Scott, EJ; Vonderheid, EC, 1989) |
| "Dogs with malignant lymphoma were given chemotherapy consisting of nitrogen mustard, vincristine sulfate, prednisone, L-asparaginase, and 6-mercaptopurine (MOPA-6) for 14 days." | 3.67 | Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation. ( Appelbaum, FR; Deeg, HJ; Graham, TC; Hackman, RC; Storb, RC; Weiden, PL, 1985) |
| "Sixty-seven evaluable patients with mixed cellular and histiocytic lymphomas, both nodular and diffuse, were treated with a combined drug regimen of BCNU, cyclophosphamide, vincristine, and prednisone administered for six monthly courses." | 3.65 | 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma. ( Chan, YK; Dorfman, R; Durant, JR; Loeb, V, 1975) |
| " Seventeen patients with Hodgkin's disease and 15 with non-Hodgkin's lymphoma were subjected to nontherapeutic splenectomy as part of the staging procedure prior to their initial treatment with MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) or CVP (cyclophosphamide, vincristine, and prednisone) chemotherapy, respectively." | 3.65 | Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. ( Canellos, GP; DeVita, VT; Ihde, DC; Young, RC, 1976) |
| " A comparison of drug dosage in the group receiving TPN and the group receiving standard nutrition is a measure of drug tolerance in these patients." | 2.65 | A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance. ( Brennan, MF; Fisher, RI; Popp, MB; Simon, RM, 1981) |
| "The response rate and survival in diffuse histiocytic lymphoma have improved since the first study." | 2.64 | Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group. ( Coltman, CA; Jones, SE; Luce, JK; McKelvey, EM; Moon, TE, 1977) |
| " This side effect could be explained by a cycling of the hematopoietic stem-cells and call to some caution when androgens are used during cancer chemotherapy." | 2.64 | [Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)]. ( Barthélémy, M; Bilski-Pasquier, G; Blanc, CM; Bouchard, M; Bousser, J; Zittoun, R, 1977) |
| "Recent progress in the chemotherapy of malignant lymphoma is described from the viewpoint of survival advantage." | 2.39 | [Recent progress in the chemotherapy of malignant lymphoma]. ( Tobinai, K, 1995) |
| "Chemotherapy of malignant lymphomas has accomplished a significant progress during the two decades." | 2.38 | [Current status of chemotherapy in the treatment of malignant lymphomas]. ( Hayashi, K; Kimura, I; Mizuta, J; Murashima, M; Ohnoshi, T; Tada, A; Tagawa, S; Ueno, K, 1989) |
| "Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches." | 2.37 | Early-stage Hodgkin's disease: current approaches to treatment. ( MacKenzie, R; Rusthoven, JJ, 1985) |
| "Patients treated for Hodgkin's disease and non-Hodgkin lymphomas were followed for 5 years after start of therapy." | 1.30 | Five-year follow-up of saliva in patients treated for lymphomas. ( Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L, 1997) |
| "3 microM, ethacrynic acid was toxic to 8 of 24 (33%) tumor specimens studied." | 1.28 | Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues. ( Kern, DH; Messenger, JC; Nagourney, RA; Weisenthal, LM, 1990) |
| "In 1984, the complete remission of malignant lymphoma was observed after MOPP, COPP and VAPP chemotherapies." | 1.28 | [Secondary leukemia (AML) with TcR beta rearrangement]. ( Akiyoshi, T; Hisano, S; Ishibashi, M; Kawara, T; Kikuchi, M; Kimura, N; Kyoshoin, K; Morioka, E; Okumura, M, 1989) |
| "Thirty-four subsequent second malignant neoplasms were observed in 33 patients among those treated for Hodgkin's disease." | 1.27 | Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. ( DeVita, VT; Glatstein, E; Kelley, PA; Kinsella, TJ; Makuch, RW; Tester, WJ; Waller, B, 1984) |
| "Menadiol was tested alone and in combination with standard antineoplastic agents." | 1.27 | Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms. ( Dill, PL; Duarte, TE; Su, YZ; Weisenthal, LM, 1987) |
| "A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP." | 1.27 | Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease. ( Eridani, S; Singh, AK, 1986) |
| "In addition, acute renal failure developed in both patients, and myolysis in one." | 1.27 | Purpura fulminans in pneumococcal sepsis. ( Berneman, ZN; Bieger, R; Bridts, C; Buyssens, N; Hautekeete, ML; Peetermans, ME; Stevens, WJ, 1986) |
| "Thirty-four patients with Hodgkin's disease and non-Hodgkin's lymphoma underwent therapeutic splenectomies to improve hematologic tolerance for chemotherapy." | 1.27 | The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas. ( Cox, RS; Hoppe, RT; Jacobs, C; Rosenberg, SA; Schreiber, DP, 1985) |
| "A strategy for treatment of malignant lymphoma requires fundamentally a field of multidisciplinary treatment including mainly radiotherapy and chemotherapy in a collaboration with surgical procedure and immunotherapeutic maneuver." | 1.27 | [Malignant lymphoma]. ( Kita, K; Shirakawa, S; Tanaka, I, 1985) |
| "Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic abnormalities of the bone marrow." | 1.27 | Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. ( Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM, 1985) |
| "The eight patients who reported pretreatment nausea had more extensive disease than the other patients and had received twice as much chemotherapy." | 1.26 | Pretreatment nausea in cancer chemotherapy: a conditioned response? ( Carli, T; Curtis, GC; Kleinman, PD; Nesse, RM, 1980) |
| "Mycosis fungoides is a cutaneously-derived malignant lymphoma which, without effective treatment, may run an unrelenting, rapidly lethal course." | 1.26 | Mycosis fungoides: clinical and therapeutic review. ( Basler, RS; Lynch, PJ, 1979) |
| "Urethane is the best treatment available for multiple myeloma." | 1.23 | New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 213 (88.38) | 18.7374 |
| 1990's | 14 (5.81) | 18.2507 |
| 2000's | 7 (2.90) | 29.6817 |
| 2010's | 5 (2.07) | 24.3611 |
| 2020's | 2 (0.83) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmerman, K | 1 |
| Walsh, KA | 1 |
| Ferrari, JT | 1 |
| Keuler, NS | 1 |
| Atherton, MJ | 1 |
| Lenz, JA | 1 |
| Martin, OA | 1 |
| Price, J | 1 |
| MaloneyHuss, MA | 1 |
| Mauldin, GE | 1 |
| Brown, DC | 1 |
| Veluvolu, SM | 1 |
| Krick, EL | 1 |
| Back, AR | 1 |
| Schleis, SE | 1 |
| Smrkovski, OA | 1 |
| Lee, J | 1 |
| Smith, AN | 1 |
| Phillips, JC | 1 |
| Sonbol, MB | 1 |
| Rana, V | 1 |
| Kenderian, SS | 1 |
| Finnes, H | 1 |
| Witzig, TE | 1 |
| Zietman, AL | 1 |
| HUNTER, OB | 1 |
| EICHENLAUB, FJ | 1 |
| OLIVO, MA | 1 |
| WINTROBE, MM | 3 |
| HUGULEY, CM | 2 |
| SHERRY, M | 1 |
| Northrup, NC | 1 |
| Gieger, TL | 1 |
| Kosarek, CE | 1 |
| Saba, CF | 1 |
| LeRoy, BE | 1 |
| Wall, TM | 1 |
| Hume, KR | 1 |
| Childress, MO | 1 |
| Keys, DA | 1 |
| ALPERT, LK | 1 |
| PETERSON, SS | 1 |
| GOODMAN, LS | 1 |
| Rassnick, KM | 1 |
| Bailey, DB | 1 |
| Malone, EK | 1 |
| Intile, JL | 1 |
| Kiselow, MA | 1 |
| Flory, AB | 1 |
| Barlow, LL | 1 |
| Balkman, CE | 1 |
| Barnard, SM | 1 |
| Waite, AH | 1 |
| Metayer, C | 1 |
| Curtis, RE | 1 |
| Vose, J | 1 |
| Sobocinski, KA | 1 |
| Horowitz, MM | 1 |
| Bhatia, S | 1 |
| Fay, JW | 1 |
| Freytes, CO | 1 |
| Goldstein, SC | 1 |
| Herzig, RH | 1 |
| Keating, A | 1 |
| Miller, CB | 1 |
| Nevill, TJ | 1 |
| Pecora, AL | 1 |
| Rizzo, JD | 1 |
| Williams, SF | 1 |
| Li, CY | 1 |
| Travis, LB | 1 |
| Weisdorf, DJ | 1 |
| NARDI, FL | 1 |
| SYKES, MP | 1 |
| GRUNDMANN, E | 1 |
| ROSE, LW | 1 |
| TUCKER, HS | 1 |
| RICHMAN, S | 1 |
| WILLIAMS, JP | 1 |
| IRWIN, GE | 1 |
| MARLOW, AA | 1 |
| BARTLETT, GR | 1 |
| RUNDLES, RW | 2 |
| BARTON, WB | 1 |
| COONRAD, EV | 1 |
| KLIMA, R | 1 |
| HORNISCHER, R | 1 |
| DEUSCHLE, KW | 1 |
| WIGGINS, WS | 1 |
| DUVERNE, J | 1 |
| BONNAYME, R | 1 |
| MOYNE, B | 1 |
| MOLINE, L | 1 |
| SILVA, MS | 1 |
| MEYER, OO | 1 |
| BOVO, G | 2 |
| D'AGNOLO, B | 2 |
| SKIMKIN, MB | 1 |
| SKINNER, EF | 1 |
| ISBELL, H | 1 |
| CARR, D | 1 |
| INTROZZI, P | 1 |
| MARINONE, G | 1 |
| HOLTHAUS, JM | 1 |
| BEATTIE, JW | 1 |
| HOWELLS, LH | 1 |
| HOCHMAN, A | 2 |
| ICKOWICZ, M | 1 |
| EBERHARD, R | 1 |
| GAJARDO, M | 1 |
| GALTON, DA | 3 |
| ISRAELS, LG | 2 |
| NABARRO, JD | 2 |
| TILL, M | 2 |
| RATH, CE | 1 |
| RATZKOWSKI, A | 1 |
| BERNARD, J | 3 |
| MATHE, G | 2 |
| WEIL, M | 3 |
| HORLIN, W | 1 |
| SCHMITT, W | 1 |
| MIDDLEBROOK, JE | 1 |
| DE VRIES, SI | 1 |
| LAMBERS, K | 1 |
| BLOCK, M | 1 |
| WILTSHAW, E | 1 |
| DIAMOND, HD | 1 |
| DOAN, CA | 1 |
| WISEMAN, BK | 1 |
| BOURONCLE, BA | 1 |
| PETRAKIS, NL | 1 |
| WOOD, DA | 2 |
| METTIER, SR | 1 |
| COSTANTINI, AV | 1 |
| FARBER, SM | 1 |
| PRESTON, FW | 1 |
| JACKSON, EJ | 1 |
| HENEGAR, GC | 1 |
| SCHREK, R | 1 |
| WINKLER, JW | 1 |
| CAPUTI, S | 1 |
| PERRONE, V | 1 |
| FAIELLA, A | 1 |
| ZARRILLI, D | 1 |
| ROOSA, RA | 1 |
| DELAMATER, ED | 1 |
| THEOLOGIDES, A | 1 |
| KENNEDY, BJ | 2 |
| OETTGEN, HF | 1 |
| CLIFFORD, P | 2 |
| BURKITT, D | 1 |
| MOLANDER, DW | 1 |
| CALCUTT, G | 2 |
| CONNORS, TA | 1 |
| MARK, JB | 1 |
| GOLDENBERG, IS | 1 |
| MONTAGUE, AC | 1 |
| ZEZZANETO, L | 1 |
| SOERENSEN, B | 1 |
| SALIBA, AM | 1 |
| GRECCHI, R | 1 |
| SMITH, JC | 2 |
| CREPALDI, G | 1 |
| PARPAJOLA, A | 1 |
| MEYER, LM | 1 |
| FLIEDNER, TD | 1 |
| CRONKITE, EP | 1 |
| MURPHY, WT | 1 |
| BILGE, N | 1 |
| MCALISTER, WH | 1 |
| MARGULIS, AR | 1 |
| BURNINGHAM, RA | 1 |
| RESTREPO, A | 1 |
| PUGH, RP | 1 |
| BROWN, EB | 1 |
| SCHLOSSMAN, SF | 1 |
| KHURI, PD | 1 |
| LESSNER, HE | 1 |
| HARRINGTON, WJ | 1 |
| TANIDA, T | 1 |
| PAPAC, RJ | 1 |
| DUNNING, WF | 1 |
| CURTIS, MR | 1 |
| IRIARTE, P | 1 |
| JAGASIA, H | 1 |
| THURMAN, WG | 1 |
| KARNOFSKY, DA | 2 |
| HUTCHISON, JL | 1 |
| CLARKSON, B | 1 |
| ROBINSON, BE | 1 |
| HOYNE, RM | 1 |
| KEIDAN, SE | 1 |
| MAINWARING, D | 1 |
| HALNAN, KE | 1 |
| BOLANDE, RP | 1 |
| CONKLIN, JW | 1 |
| UPTON, AC | 1 |
| CHRISTENBERRY, KW | 1 |
| LUPOVITCH, A | 1 |
| KATASE, RY | 1 |
| RANDALL, HP | 1 |
| BELLAMY, MD | 1 |
| SKINNER, DB | 1 |
| SALZMAN, EW | 1 |
| SCANNELL, JG | 1 |
| MORROW, LB | 1 |
| ANDERSON, RE | 1 |
| LIBANSKY, J | 1 |
| CHUDOMEL, V | 1 |
| BRABEC, V | 1 |
| SOCHMAN, J | 1 |
| MOLIN, B | 1 |
| RABENKO, J | 2 |
| CORREA URQUIZA, LM | 1 |
| JAMRA, M | 1 |
| MILDER, R | 1 |
| LASZLO, J | 1 |
| GRIZZLE, J | 1 |
| JONSSON, U | 1 |
| MASOUREDIS, SP | 1 |
| LOW-BEER, BV | 1 |
| BIERMAN, HR | 2 |
| CHERNEY, LS | 1 |
| SHIMKIN, MB | 2 |
| BADER, DN | 1 |
| LEVI, M | 1 |
| MENE, G | 1 |
| FERRI, A | 1 |
| JOYEUX, R | 1 |
| COURTY, A | 1 |
| BERTRAND, L | 1 |
| de LORENZO, J | 1 |
| JANNINI, P | 1 |
| KELLY, KH | 1 |
| LOWENHAUPT, E | 1 |
| FURST, A | 1 |
| BERTLICH, W | 1 |
| HEITE, HJ | 1 |
| GARCIA PEREZ, A | 1 |
| QUINONES CARAVIA, PA | 1 |
| KIELER, J | 1 |
| MELICK, RA | 1 |
| SWEITZER, SE | 1 |
| CUMMING, HA | 1 |
| McAFEE, GD | 1 |
| CABY, F | 1 |
| TSEVRENIS, H | 1 |
| Yamanaka, R | 3 |
| Morii, K | 3 |
| Shinbo, Y | 3 |
| Takeuchi, S | 1 |
| Tamura, T | 3 |
| Hondoh, H | 3 |
| Takahashi, H | 4 |
| Onda, K | 2 |
| Tanaka, R | 3 |
| Björkholm, M | 1 |
| Celsing, F | 1 |
| Johansson, E | 1 |
| Sano, M | 2 |
| Homma, J | 2 |
| Tsuchiya, N | 2 |
| Yajima, N | 2 |
| BEN-ASHER, S | 1 |
| MEYER, AH | 1 |
| OVERMILLER, WC | 1 |
| AUB, JC | 1 |
| Kakuma, T | 1 |
| Bruce, WR | 1 |
| Waldorf, DS | 1 |
| Haynes, HA | 1 |
| Van Scott, EJ | 3 |
| Rupniewska, ZM | 1 |
| Kurowska, M | 1 |
| Klastersky, J | 1 |
| Freireich, EJ | 1 |
| Keating, M | 1 |
| Cabanillas, F | 1 |
| Barlogie, B | 1 |
| Portlock, CS | 2 |
| Jacquillat, C | 1 |
| Khayat, D | 1 |
| Desprez-Curely, JP | 1 |
| Brocheriou, C | 1 |
| Auclerc, G | 1 |
| Chamseddine, N | 1 |
| Körbling, M | 1 |
| Hunstein, W | 1 |
| Broder, S | 1 |
| Bunn, PA | 2 |
| Voltarelli, JC | 1 |
| Falcão, RP | 1 |
| Bottura, C | 1 |
| Tester, WJ | 1 |
| Kinsella, TJ | 2 |
| Waller, B | 1 |
| Makuch, RW | 1 |
| Kelley, PA | 1 |
| Glatstein, E | 2 |
| DeVita, VT | 8 |
| Sampi, K | 2 |
| Honda, T | 2 |
| Hattori, M | 2 |
| Leung, AC | 1 |
| McKean, M | 1 |
| Mactier, R | 1 |
| Dobbie, JW | 1 |
| Heinz, R | 1 |
| Hanak, H | 1 |
| Fisher, RI | 5 |
| Hubbard, SM | 3 |
| Longo, DL | 4 |
| Wesley, R | 1 |
| Chabner, BA | 2 |
| Young, RC | 5 |
| Weiss, VC | 1 |
| Barsky, GJ | 1 |
| Solomon, LM | 1 |
| Carney, DN | 1 |
| Hamminga, L | 1 |
| Hermans, J | 1 |
| Noordijk, EM | 1 |
| Meijer, CJ | 1 |
| Scheffer, E | 1 |
| Van Vloten, WA | 1 |
| Popp, MB | 1 |
| Simon, RM | 1 |
| Brennan, MF | 1 |
| Nesse, RM | 1 |
| Carli, T | 1 |
| Curtis, GC | 1 |
| Kleinman, PD | 1 |
| Kantor, G | 1 |
| Cosset, JM | 1 |
| Masselot, J | 1 |
| Horikoshi, N | 1 |
| Ogawa, M | 2 |
| Gomez, GA | 1 |
| Aggarwal, KK | 1 |
| Han, T | 1 |
| Golomb, HM | 1 |
| Sweet, DL | 1 |
| Tobinai, K | 2 |
| Watkins, SM | 1 |
| Weltin, D | 1 |
| Marchal, J | 1 |
| Dufour, P | 1 |
| Potworowski, E | 1 |
| Oth, D | 1 |
| Bischoff, P | 1 |
| Bhattacharya, S | 1 |
| Ganguly, C | 1 |
| Sanyal, U | 1 |
| Das, S | 1 |
| O'Connor, PM | 1 |
| Ferris, DK | 1 |
| Pagano, M | 1 |
| Draetta, G | 1 |
| Pines, J | 1 |
| Hunter, T | 1 |
| Kohn, KW | 1 |
| Meurman, JH | 1 |
| Laine, P | 1 |
| Keinànen, S | 1 |
| Pyrhönen, S | 1 |
| Teerenhovi, L | 1 |
| Lindqvist, C | 1 |
| Bairey, O | 1 |
| Gabbay, U | 1 |
| Blickstein, D | 1 |
| Stark, P | 1 |
| Prokocimer, M | 1 |
| Epstein, O | 1 |
| Shaklai, M | 1 |
| Lahav, J | 1 |
| Estève, E | 1 |
| Bagot, M | 1 |
| Joly, P | 1 |
| Souteyrand, P | 1 |
| Beylot-Barry, M | 1 |
| Vaillant, L | 1 |
| Delaunay, M | 1 |
| Avril, MF | 1 |
| Laroche, L | 1 |
| Grange, F | 1 |
| Thomine, E | 1 |
| Wechsler, J | 1 |
| Wu, HG | 1 |
| Kim, IH | 1 |
| Ha, SW | 1 |
| Park, CI | 1 |
| Bang, YJ | 1 |
| Huh, DS | 1 |
| Krakoff, IH | 1 |
| Vettore, L | 1 |
| Pizzolo, G | 1 |
| Kolarić, K | 2 |
| Maricić, Z | 1 |
| Dujmović, I | 1 |
| Mrsić, Z | 1 |
| Pasmantier, MW | 1 |
| Coleman, M | 1 |
| Silver, RT | 1 |
| Bennett, JM | 1 |
| Bakemeier, RF | 1 |
| Carbone, PP | 3 |
| Ezdinli, E | 1 |
| Lenhard, RE | 2 |
| Constantine, VS | 1 |
| Anderson, T | 1 |
| Bender, RA | 1 |
| Berard, CW | 1 |
| Norton, L | 1 |
| Coltman, CA | 1 |
| Luce, JK | 1 |
| McKelvey, EM | 1 |
| Jones, SE | 1 |
| Moon, TE | 1 |
| Maruyama, Y | 2 |
| Sieber, SM | 1 |
| Weiden, PL | 2 |
| Storb, R | 1 |
| Deeg, HJ | 2 |
| Graham, TC | 2 |
| Thomas, ED | 1 |
| Basler, RS | 1 |
| Lynch, PJ | 1 |
| Kluin-Neleman, JC | 1 |
| Neleman, FA | 1 |
| Meuwissen, OJ | 1 |
| Maes, RA | 1 |
| Merriman, RL | 1 |
| Sladek, NE | 1 |
| Neretto, G | 1 |
| Giovanelli, E | 1 |
| Agricola, R | 1 |
| Furno, F | 1 |
| Roth, A | 1 |
| Cerlek, S | 1 |
| Dominis, M | 1 |
| Klein, HO | 1 |
| Bar-Meir, S | 1 |
| Pinkhas, J | 1 |
| Golan, A | 1 |
| Vries, A | 1 |
| Oluboyede, OA | 1 |
| Olaofe, WA | 1 |
| Esan, GJ | 1 |
| Zittoun, R | 1 |
| Barthélémy, M | 1 |
| Bouchard, M | 1 |
| Blanc, CM | 1 |
| Bousser, J | 1 |
| Bilski-Pasquier, G | 1 |
| Raju, MR | 1 |
| Bains, E | 1 |
| Jett, J | 1 |
| Viollier, AF | 1 |
| Senn, HJ | 1 |
| Durant, JR | 1 |
| Loeb, V | 1 |
| Dorfman, R | 1 |
| Chan, YK | 1 |
| Sahakian, GJ | 1 |
| Ihde, DC | 2 |
| Canellos, GP | 1 |
| Wollner, N | 1 |
| Hall, AG | 1 |
| Tilby, MJ | 1 |
| Levy, LM | 1 |
| Sonqishe, M | 1 |
| Nagourney, RA | 1 |
| Messenger, JC | 1 |
| Kern, DH | 1 |
| Weisenthal, LM | 2 |
| Li, XJ | 1 |
| Zhao, BL | 1 |
| Hou, JW | 1 |
| Xin, WJ | 1 |
| Xie, RF | 1 |
| Chen, YR | 1 |
| Shirakawa, S | 1 |
| Tanaka, I | 1 |
| Kita, K | 1 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Bron, D | 1 |
| Vandenheule, B | 1 |
| Stryckmans, P | 1 |
| Bonadonna, G | 1 |
| Inagaki, J | 1 |
| Gulati, SC | 1 |
| Atzpodien, J | 1 |
| Langleben, A | 1 |
| Shimazaki, C | 1 |
| Jain, K | 1 |
| Yopp, J | 1 |
| Ng, RP | 1 |
| Colvin, OM | 1 |
| Clarkson, BD | 1 |
| Straus, DJ | 1 |
| Vonderheid, EC | 2 |
| Tan, ET | 1 |
| Kantor, AF | 1 |
| Shrager, L | 1 |
| Micaily, B | 2 |
| Akiyoshi, T | 1 |
| Kimura, N | 1 |
| Hisano, S | 1 |
| Kawara, T | 1 |
| Morioka, E | 1 |
| Ishibashi, M | 1 |
| Kyoshoin, K | 1 |
| Kikuchi, M | 1 |
| Okumura, M | 1 |
| Longo, D | 1 |
| Ohnoshi, T | 1 |
| Hayashi, K | 1 |
| Ueno, K | 1 |
| Tada, A | 1 |
| Murashima, M | 1 |
| Mizuta, J | 1 |
| Tagawa, S | 1 |
| Kimura, I | 1 |
| Duffey, PL | 1 |
| Jaffe, ES | 1 |
| Gilliom, M | 1 |
| Love, RR | 1 |
| Leventhal, H | 1 |
| Easterling, DV | 1 |
| Nerenz, DR | 1 |
| De Vita, VT | 1 |
| Su, YZ | 1 |
| Duarte, TE | 1 |
| Dill, PL | 1 |
| Begleiter, A | 1 |
| Eridani, S | 1 |
| Singh, AK | 1 |
| Hautekeete, ML | 1 |
| Berneman, ZN | 1 |
| Bieger, R | 1 |
| Stevens, WJ | 1 |
| Bridts, C | 1 |
| Buyssens, N | 1 |
| Peetermans, ME | 1 |
| Toner, GC | 1 |
| Sinclair, RA | 1 |
| Sutherland, RC | 1 |
| Schwarz, MA | 1 |
| Schreiber, DP | 1 |
| Jacobs, C | 1 |
| Rosenberg, SA | 2 |
| Cox, RS | 1 |
| Hoppe, RT | 1 |
| Perri, RT | 1 |
| Allen, JI | 1 |
| Oken, MM | 1 |
| Limas, C | 1 |
| Kay, NE | 1 |
| Frei, E | 2 |
| Kaplan, HS | 1 |
| Johnson, DH | 1 |
| Linde, R | 1 |
| Hainsworth, JD | 1 |
| Vale, W | 1 |
| Rivier, J | 1 |
| Stein, R | 1 |
| Flexner, J | 1 |
| Van Welch, R | 1 |
| Greco, FA | 1 |
| Rusthoven, JJ | 1 |
| MacKenzie, R | 1 |
| Appelbaum, FR | 1 |
| Hackman, RC | 1 |
| Storb, RC | 1 |
| King, DJ | 1 |
| Ratcliffe, MA | 1 |
| Dawson, AA | 1 |
| Bennett, B | 1 |
| Macgregor, JE | 1 |
| Klopper, AI | 1 |
| Pedersen-Bjergaard, J | 1 |
| Ersbøll, J | 1 |
| Sørensen, HM | 1 |
| Keiding, N | 1 |
| Larsen, SO | 1 |
| Philip, P | 1 |
| Larsen, MS | 1 |
| Schultz, H | 1 |
| Nissen, NI | 1 |
| Flexner, JM | 1 |
| Ting, SM | 1 |
| Preece, AV | 1 |
| Peterson, AR | 1 |
| Fox, BW | 1 |
| Fox, M | 2 |
| Jeney, A | 1 |
| Fov, BW | 1 |
| Anderson, D | 1 |
| Schabel, FM | 1 |
| Goldin, A | 1 |
| Lawhorn, TI | 1 |
| Stone, HH | 1 |
| Martin, JD | 1 |
| Solomon, J | 1 |
| Jacobs, EM | 1 |
| Bateman, JR | 1 |
| Lukes, RJ | 1 |
| Weiner, JM | 1 |
| Donohue, DM | 1 |
| Rubin, P | 1 |
| Valeriote, FA | 1 |
| Tolen, SJ | 1 |
| Jolley, GM | 1 |
| Ormerod, MG | 1 |
| Levitt, SH | 1 |
| Jones, TK | 1 |
| Kilpatrick, SJ | 1 |
| Bogardus, CR | 1 |
| Ultmann, JE | 1 |
| Nixon, DD | 1 |
| Garrett, MJ | 1 |
| Glazebrook, GA | 1 |
| el-Akkad, SM | 1 |
| Shakir, MA | 1 |
| Fairley, GH | 1 |
| Cywes, S | 1 |
| Berceanu, S | 1 |
| Gociu, M | 1 |
| Geib, R | 1 |
| Sighetea, E | 1 |
| Dăncescu, I | 1 |
| Segal, E | 1 |
| Tănăsescu, C | 1 |
| DeConti, RC | 1 |
| Kaplan, SR | 1 |
| Calabresi, P | 1 |
| Goldenberg, GJ | 1 |
| Lyons, RM | 1 |
| Lepp, JA | 1 |
| Vanstone, CL | 1 |
| Owens, AH | 1 |
| Todd, ID | 1 |
| Chambers, RG | 1 |
| Alonso, WA | 1 |
| Wasastjerna, C | 1 |
| Elalouf, C | 1 |
| Girard, J | 1 |
| Durepaire, R | 1 |
| Grupper, MC | 1 |
| Märki, HH | 1 |
| Bishop, RC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| (PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older[NCT01453088] | Phase 2 | 63 participants (Actual) | Interventional | 2010-06-24 | Terminated (stopped due to Lack of Accrual) | ||
| Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma[NCT01241708] | Phase 3 | 146 participants (Actual) | Interventional | 2010-04-08 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01453088)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 27 |
| Auto Transplant High Dose Melphalan+Bortezomib | 27 |
Progression free survival of elderly patients with multiple myeloma treated with either high-dose melphalan versus high-dose melphalan and bortezomib at 3 years (NCT01453088)
Timeframe: Participants will be followed post transplant for a minimum of 3 years, and after that may be monitored as part of the study indefinitely
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 13 |
| Auto Transplant High Dose Melphalan+Bortezomib | 11 |
24 reviews available for mechlorethamine and Lymphoma
| Article | Year |
|---|---|
The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxor | 1984 |
"Good risk" non-Hodgkin lymphomas: approaches to management.
Topics: Actuarial Analysis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1983 |
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1984 |
In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy.
Topics: Acute Disease; Animals; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Disease Models, | 1984 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyt | 1995 |
[Recent progress in the chemotherapy of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 1995 |
Chemotherapy of the non-Hodgkin's lymphomas.
Topics: Antineoplastic Agents; Bleomycin; Chlorambucil; Cortisone; Cyclophosphamide; Doxorubicin; Drug Thera | 1976 |
Current concepts in mycosis fungoides: its nosology, diagnosis and treatment.
Topics: Humans; Immunotherapy; Lymph Nodes; Lymphoma; Mechlorethamine; Mycosis Fungoides; Nitrosourea Compou | 1976 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; | 1977 |
Human models of human diseases; breast cancer and the lymphomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; | 1979 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Advances in lymphoma treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Forecasting; Humans; Im | 1992 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethaso | 1985 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1985 |
[Drug therapy of malignant lymphoma].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1985 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
[Current status of chemotherapy in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphoma; Mechlore | 1987 |
Early-stage Hodgkin's disease: current approaches to treatment.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem | 1985 |
Treatment of cutaneous T-cell lymphoma.
Topics: Adjuvants, Immunologic; Administration, Topical; Carmustine; Combined Modality Therapy; Humans; Immu | 1985 |
Chemotherapy in solid tumors of childhood.
Topics: Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Eye Neopla | 1972 |
The therapy of lymphoma.
Topics: Adrenal Cortex Hormones; Asparaginase; Bone Marrow Diseases; Chlorambucil; Cyclophosphamide; Cytarab | 1969 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin | 1971 |
14 trials available for mechlorethamine and Lymphoma
| Article | Year |
|---|---|
Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Cyclophosphamide; Dog Diseases; | 2010 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combi | 2007 |
A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin | 1981 |
Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug | 1982 |
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous | 1999 |
Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
Topics: Bleomycin; Carmustine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug T | 1976 |
Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; | 1977 |
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
Topics: Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration | 1977 |
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Topics: Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combinatio | 1979 |
[Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)].
Topics: Androgens; Anemia; Antineoplastic Agents; Drug Therapy, Combination; Humans; Lymphoma; Mechlorethami | 1977 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine | 1985 |
Chemotherapy of lymphoma with mechlorethamine and vinblastine.
Topics: Adult; Blood Cell Count; Blood Platelet Disorders; Clinical Trials as Topic; Evaluation Studies as T | 1973 |
Treatment of malignant superior vena caval obstruction. A randomized study.
Topics: Adenocarcinoma; Blood Pressure; Carcinoma; Carcinoma, Squamous Cell; Diuretics; Humans; Lymphoma; Ly | 1969 |
204 other studies available for mechlorethamine and Lymphoma
| Article | Year |
|---|---|
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Doxorubicin; Lymphoma; | 2023 |
Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Disease-Free Survival; | 2018 |
Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Lymphoma; Mechlorethami | 2020 |
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lymphoma; Lymph | 2015 |
Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortage.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2014 |
Fifty years from Paris: the remarkable story of the lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Congresses as Topic; History, 19th Century; History, | 2015 |
Unusual changes in lymphosarcoma under nitrogen mustard therapy.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine | 1948 |
Nitrogen mustard therapy of lymphosarcoma; report of a case.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Compounds; Mustard Plant; Neoplasms; Nitro | 1948 |
Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Plant; Nitrogen | 1948 |
Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco | 1948 |
Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; | 2009 |
Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine | 1947 |
The use of nitrogen mustard in the treatment of lymphomata.
Topics: Ethylamines; Immunity; Lymphatic System; Lymphoma; Mechlorethamine; Neoplasms | 1947 |
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: Amines; Gas Poisoning; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechloret | 1946 |
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth | 2003 |
[Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
Treatment of the leukemias and lymphomas; current trends.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1952 |
[Caryologic and caryometric determinations in lymph node punctures in nitrogen mustard therapy].
Topics: Lymph Nodes; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Punctures | 1952 |
Combined nitrogen mustard and single dose irradiation treatment of lymphomata and other malignant tumors.
Topics: Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Neoplasms; Radiotherapy Dosage | 1952 |
Recent advances in treatment of leukemias and lymphomas.
Topics: Humans; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
New therapy for leukemia, polycythemia, and lymphoma.
Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple | 1953 |
The role of chemotherapy in the management of malignant lymphomas and leukemias.
Topics: Adrenocorticotropic Hormone; Cortisone; Disease Management; Folic Acid Antagonists; Humans; Leukemia | 1953 |
[Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
Topics: Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymp | 1953 |
The use of nitrogen mustard in the management of two pregnant lymphoma patients.
Topics: Disease Management; Fetus; Hodgkin Disease; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; P | 1953 |
[Reticulosis simulating mycosis fungoides, poikilodermic in the beginning with reticular blood cells at the end, coincident with radiophosphorus].
Topics: Blood Cells; Diagnosis, Differential; Humans; Lymphoma; Mechlorethamine; Mycosis Fungoides; Nitrogen | 1953 |
[Lymphoma fungoides (mycosis fungoides); nitrogen mustard therapy].
Topics: Humans; Lymphoma; Mechlorethamine; Mycosis Fungoides; Nitrogen Mustard Compounds | 1952 |
Treatment of Hodgkin's disease and the lymphosarcomas.
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compound | 1954 |
[Nitrogen mustard gas therapy of tuberculous lymphoma].
Topics: Lymph Nodes; Lymphoma; Mechlorethamine; Mustard Gas; Mustard Plant; Nitrogen; Nitrogen Mustard Compo | 1953 |
Pulmonary-tumor induction in mice with chemical agents used in the clinical management of lymphomas.
Topics: Animals; Carcinogens; Lung Neoplasms; Lymphoma; Mechlorethamine; Mice; Neoplasms, Experimental; Nitr | 1954 |
Disseminated lymphoblastoma resembling pulmonary tuberculosis; temporary dramatic response to nitrogen mustard therapy; case report.
Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Tuberculosis, | 1954 |
[Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
Topics: Ethylamines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1953 |
Chemotherapy of lymphomas and leukemia.
Topics: Adrenocorticotropic Hormone; Cortisone; Folic Acid Antagonists; Humans; Leukemia; Lymphoma; Mechlore | 1954 |
Biological actions and therapeutic applications of nitrogen mustard.
Topics: Hodgkin Disease; Leukemia; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitr | 1954 |
Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases.
Topics: Cortisone; Hodgkin Disease; Lymphocytes; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen | 1954 |
[Lymphosarcoma in children].
Topics: Child; Infant; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Radioth | 1954 |
Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.
Topics: Chlorambucil; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Phenylbutyrates | 1955 |
the use of nitrogen mustard in the treatment of lymphoblastomas.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
[The resistant stage in lymphoblastomic diseases].
Topics: Cortisone; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
[Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoid Tiss | 1956 |
[Treatment of hematologic neoplasms with nitrogen oxide mustards].
Topics: Hematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Mechlorethamine; Mustard Plant; Nitrogen | 1957 |
[Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1957 |
Hypofibrinogenemia without fibrinolysis associated with a lymphoma and controlled after treatment with cortisone and nitrogen mustard.
Topics: Afibrinogenemia; Cortisone; Fibrinolysis; Humans; Lymphoma; Mechlorethamine; Nitrogen Mustard Compou | 1957 |
Treatment of malignant lymphoma with chlorambucil (CB 1348, leukeran).
Topics: Chlorambucil; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
[Treatment of lymphosarcoma].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
Histopathologic effects of x-rays, radiophosphorus, nitrogen mustard, urethane, and steroids upon the spleen in leukemias and lymphomas.
Topics: Adrenocorticotropic Hormone; Cortisone; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compou | 1958 |
Clinical evaluation of CB 1348 in malignant lymphoma and related diseases.
Topics: Chlorambucil; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1958 |
Clinical evaluation of CB 1348 in leukemias and lymphomas.
Topics: Chlorambucil; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
Preliminary clinical evaluation of 1, 2-bis(beta-chloroethylthylthio) ethane (SM-1) in patients with advanced lymphomas and neoplastic diseases.
Topics: Antineoplastic Agents; Ethane; Lymphoma; Mechlorethamine; Mustard Gas; Myosin-Light-Chain Kinase; Ne | 1958 |
A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin's disease, lymphosarcoma, and melanoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Hodgkin Disease; Humans; Leucine; Lymphoma; Lymphoma | 1959 |
Antitumor effects of homologous immune serum, immune lymphocytes and nitrogen mustard against a rat lymphoma.
Topics: Animals; Immune Sera; Lymphocytes; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Rats | 1958 |
Hyperuricemia with uric acid nephropathy following nitrogen mustard therapy of lymphosarcoma; report of a case.
Topics: Hyperuricemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Uric Ac | 1959 |
The histopathological changes induced by the nitrogen mustards in the lymphomas: a brief review of the literature.
Topics: Hodgkin Disease; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
[Observations & results in patients with malignant hemolymphatic diseases treated with p-(N,N-di-2-chloroethyl) aminophenylbutyric acid (CB 1348)].
Topics: Chlorambucil; Lymphoma; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1959 |
A cytological evaluation of combined therapy in the 6C3HED lymphosarcoma. I. -SH-containing analogs in combination with nitrogen mustard and mapharsen.
Topics: Antineoplastic Agents; Arsenicals; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Organic | 1960 |
Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
Topics: Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Minnesota; Nitrogen Mustard Compounds; Urac | 1962 |
Malignant lymphoma involving the jaw in African children: treatment with alkylating agents and actinomycin D.
Topics: Alkylating Agents; Aziridines; Child; Cyclophosphamide; Dactinomycin; Humans; Jaw; Lymphoma; Mechlor | 1963 |
THE MALIGNANT LYMPHOMAS.
Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma | 1963 |
TUMOUR SULPHYDRYL LEVELS AND SENSITIVITY TO THE NITROGEN MUSTARD MEROPHAN.
Topics: Animals; Lymphoma; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mechlorethamine; Mela | 1963 |
INTRAPLEURAL MECHLORETHAMINE HYDROCHLORIDE THERAPY FOR MALIGNANT PLEURAL EFFUSION.
Topics: Breast Neoplasms; Drainage; Female; Humans; Lung Neoplasms; Lymphoma; Mechlorethamine; Neoplasm Meta | 1964 |
[TEST OF THE ACTION OF SOME NITROGEN MUSTARD DERIVATIVES ON STICKER'S LYMPHOSARCOMA].
Topics: Animals; Cyclophosphamide; Dogs; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Neopla | 1963 |
RADIATION PNEUMONITIS. CASE REPORT OF BILATERAL REACTION AFTER UNILATERNAL IRRADIATION.
Topics: Child; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mediastinal Neoplasms | 1964 |
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky | 1964 |
AUTOLOGOUS BONE-MARROW TRANSFUSION FOLLOWING CHEMOTHERAPY.
Topics: Autoradiography; Biomedical Research; Blood Cell Count; Blood Platelets; Bone Marrow; Bone Marrow Tr | 1964 |
COMPRESSION OF THE SPINAL CORD IN PATIENTS WITH MALIGNANT LYMPHOMA.
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret | 1964 |
COMPARISON OF EFFECTS OF CHEMOTHERAPY AND LOCAL IRRADIATION ON THE VASCULARITY OF A TRANSPLANTED MOUSE LYMPHOSARCOMA; A STUDY USING ANGIOGRAPHY AND MICROANGIOGRAPHY.
Topics: Angiography; Animals; Blood Vessels; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Neoplas | 1964 |
WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS.
Topics: Anemia; Anemia, Hemolytic; Betamethasone; Chlorambucil; Dexamethasone; Geriatrics; Humans; Leukemia; | 1964 |
[HISTOPATHOLOGICAL EFFECTS OF ANTINEOPLASTIC AGENTS ON MALIGNANT LYMPHOMA].
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Hodgkin Dise | 1964 |
LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1964 |
COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
Topics: Animals; Benzaldehydes; Carcinoma, Bronchogenic; Carcinoma, Hepatocellular; Female; Humans; Injectio | 1964 |
LYMPHANGIOGRAPHY FOR MALIGNANT DISEASES IN CHILDREN.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Myeloid; Lymph Nodes; Lympha | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
THE MANAGEMENT OF MALIGNANT DISEASE OF THE HEAD AND NECK AREA IN EAST AFRICA.
Topics: Africa; Africa, Eastern; Black People; Burkitt Lymphoma; Busulfan; Carcinoma, Squamous Cell; Child; | 1964 |
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Human | 1964 |
RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adolescent; Alkylating Agents; Antimetabolites; Antineoplastic | 1964 |
LYMPHOSARCOMA PRODUCING MIKULICZ SYNDROME.
Topics: Drug Therapy; Geriatrics; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mikulicz' Diseas | 1964 |
ASSOCIATION OF HERPES ZOSTER WITH LEUKEMIA AND LYMPHOMA IN CHILDREN.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Child; Cyclophosphamide; Drug Therapy; Herpes Zoster; Ho | 1965 |
LONG-TERM RESULTS OF X-RAY TREATMENT IN MALIGNANT DISEASE OF THE LYMPHO-RETICULAR SYSTEM.
Topics: Classification; England; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodg | 1964 |
RADIATION AND DRUG INDUCED HYALINIZATION OF THE STOMACH.
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Drug Therapy; Ganglioneuroma; Gastroin | 1965 |
FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.
Topics: Aging; Busulfan; Cataract; Female; Humans; Leukemia; Leukemia, Myeloid; Longevity; Lung Neoplasms; L | 1965 |
MALIGNANT LYMPHOMA PRESENTING AS NECROTIZING EOSINOPHILIC GRANULOMATOSIS.
Topics: Bone Marrow Examination; Drug Therapy; Eosinophilic Granuloma; Lymphoma; Mechlorethamine; Mercaptopu | 1965 |
THE CHALLENGE OF SUPERIOR VENA CAVAL OBSTRUCTION.
Topics: Adenocarcinoma; Angiography; Blood Vessels; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous | 1965 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu | 1965 |
Treatment of malignant lymphomas and lymphadenoses with leukeran.
Topics: Chlorambucil; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Nitrogen Mus | 1959 |
[Experiences with palliative chemotherapy of advanced malignant lymphoma with nitrogen mustards].
Topics: Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1960 |
[The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1959 |
[Clinico-hematological observations on the use of Enduxan in lymphomas].
Topics: Cyclophosphamide; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1961 |
Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
Topics: Antineoplastic Agents; Cyclophosphamide; Lymphoma; Mannitol; Mannomustine; Mechlorethamine; Nitrogen | 1962 |
[Results obtained with the use of chlorambucil in the treatment of malignant lymphopathies].
Topics: Chlorambucil; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodg | 1961 |
Nitrogen mustards in the treatment of neoplastic disease.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis | 1950 |
The partition of radio-phosphorus (P32) in blood, urine and tumor tissue in patients with Hodgkin's disease and lymphosarcoma before and after treatment with nitrogen mustard [methyl bis (beta-chloroethyl) amine].
Topics: Amines; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Phosph | 1950 |
Treatment of lymphosarcoma with nitrogen mustard.
Topics: Animals; Dogs; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitrogen Mustard Compoun | 1951 |
[Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
Topics: Amines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas | 1951 |
[Ileo-mesenteric lymphosarcomata; trial treatment with nitrogen mustard].
Topics: Ileum; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mesentery; Neoplasms; Nitrogen Mustard Comp | 1951 |
[Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compou | 1951 |
Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases.
Topics: Animals; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma; Mechlorethamine; Mice; Neoplasms; Nitrog | 1951 |
[On nitrogen mustard therapy of mycosis fungoides. II. Histologic studies].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis Fungoides; Nitrogen Mustard Compounds | 1951 |
[Case of mycosis fungoides treated with nitrogen mustard].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis Fungoides; Nitrogen Mustard Compounds | 1951 |
Nitrogen mustard therapy in the reticuloses.
Topics: Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Peptide Nucleic Acids | 1951 |
Aromatic nitrogen mustards in the reticuloses with special reference to R48 [di(2-chloroethyl)-beta-naphthylamine].
Topics: 2-Naphthylamine; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Peptide Nucleic Acids | 1951 |
[Treatment of tuberculous lymphoma with azoyperite].
Topics: Lymph Nodes; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Tuberculosis; Tuberculosis, Lymp | 1951 |
Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1951 |
Chemotherapy in the reticuloses.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Peptide Nucleic Acids; Phosphorus; | 1952 |
[Case of mycosis fungoides].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis Fungoides; Nitrogen Mustard Compounds | 1951 |
Lymphosarcoma treated with nitrogen mustard; report of a case.
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1950 |
[Treatment of a lymphosarcoma of the neck by combination of nitrogen mustard, radiotherapy and surgery].
Topics: Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neck; Neoplasms; Nitrogen Mustard Compounds; Radio | 1950 |
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Centra | 2005 |
Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2006 |
Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
Topics: Amines; Ethylamines; Hodgkin Disease; Humans; Leukemia; Lung Diseases; Lung Neoplasms; Lymphoma; Lym | 1949 |
The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma.
Topics: Ethylamines; Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Sarcoma | 1949 |
The therapeutic indications for nitrogen mustards in lymphoma.
Topics: Ethylamines; Humans; Lymphoma; Mechlorethamine; Neoplasms | 1949 |
Results of treatment of 112 cases of primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2008 |
A model system for examining the action of anti-cancer agents at the cellular level in vivo.
Topics: Animals; Antineoplastic Agents; Azaserine; Cyclophosphamide; Dactinomycin; Fluorouracil; Hematopoies | 1967 |
Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.
Topics: Cyclophosphamide; Dermatitis, Contact; Desensitization, Immunologic; Dosage Forms; Drug Hypersensiti | 1967 |
[Chemotherapy of non-Hodgkin lymphoma with poor prognosis].
Topics: Antineoplastic Agents; Asparaginase; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Ther | 1980 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Cutaneous T-cell lymphomas.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Electrons; Female; Furocoumarins; Humans; Imm | 1980 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1984 |
[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hum | 1984 |
Acute oliguric renal failure secondary to lymphomatous infiltration of the kidneys.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Kidney Neoplasms; | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bloo | 1983 |
Cutaneous T-lymphocyte lymphoma in association with multiple myeloma.
Topics: Aged; Female; Humans; Lymphoma; Mechlorethamine; Multiple Myeloma; Neoplasms, Multiple Primary; Skin | 1984 |
[Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxo | 1983 |
Treatment of cutaneous T-cell lymphoma.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Electrons; Humans; Lymphoma; Mechlorethamine; Neop | 1980 |
Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyc | 1982 |
Pretreatment nausea in cancer chemotherapy: a conditioned response?
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Conditioning, Psycholo | 1980 |
[Advantages of thoracic CT scanning in the treatment of mediastinal lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphoma; Mechlorethamine | 1982 |
[Chemotherapy of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; | 1982 |
Deferral of initial therapy for advanced indolent lymphomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therap | 1982 |
Role of combined-modality therapy in the curative management of advanced-stage "favorable" non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Humans; | 1982 |
Diagnosis, staging, and treatment of the malignant lymphomas.
Topics: Biopsy; Cyclophosphamide; Drug Combinations; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Mechlor | 1980 |
Predicting neutropenia after chemotherapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cy | 1993 |
Effect of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell | 1994 |
Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in mice.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Body Weight; DNA, Neoplasm; Drug Evaluation, Precl | 1994 |
G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
Topics: Antigen-Antibody Complex; Aphidicolin; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-D | 1993 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Ch | 1997 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherap | 1997 |
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkyla | 1999 |
Predawn.
Topics: Antineoplastic Agents; Folic Acid Antagonists; History, 20th Century; Humans; Lymphoma; Mechloretham | 2000 |
[Criteria for choice of therapeutic procedures in lymphomas].
Topics: Antineoplastic Agents; Bleomycin; Cobalt Radioisotopes; Doxorubicin; Drug Therapy, Combination; Hodg | 1975 |
[Experience in the treatment of malignant obstructions of the vena cava superior by means of chemotherapeutic decompression and subsequent irradiation].
Topics: Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Central Venous Pressure; Decompression; Female; | 1975 |
Action of radiation or alkylating agents on LSA lymphoma during growth.
Topics: Alkylating Agents; Animals; Carmustine; Cell Survival; Cobalt Radioisotopes; Cyclophosphamide; Dose- | 1979 |
Prolonged disease-free survival in dogs with lymphoma after total-body irradiation and autologous marrow transplantation consolidation of combination-chemotherapy-induced remissions.
Topics: Animals; Antineoplastic Agents; Asparaginase; Bone Marrow Transplantation; Cyclophosphamide; Dogs; D | 1979 |
Mycosis fungoides: clinical and therapeutic review.
Topics: Humans; Lymphoma; Mechlorethamine; Methoxsalen; Mycosis Fungoides; Photochemotherapy; Sezary Syndrom | 1979 |
Cytotoxic activity of mechlorethamine and melphalan against cultured tumor cells: potentiation by caffeine.
Topics: Animals; Antineoplastic Agents; Caffeine; Carcinoma 256, Walker; Cells, Cultured; Drug Synergism; Ly | 1978 |
[Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine | 1978 |
Liver changes induced by cytostatic drugs in patients with non Hodgkin's lymphomas.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Female; Hepatitis; Humans; Liver; Liver Neoplasms; L | 1978 |
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphom | 1976 |
Malignant lymphoma presenting as unilateral exophtalmos and thyroid nodule (author's transl)
Topics: Axilla; Exophthalmos; Heart Neoplasms; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamin | 1975 |
Non-Hodgkin's lymphoma in Ibadan, Nigeria.
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Female; Humans; Lymphoma; Male; Mechlorethamine; M | 1977 |
Study of in vivo tumor state and response to therapy by analysis of DNA distribution.
Topics: Animals; Carmustine; Cell Survival; Cobalt Radioisotopes; DNA, Neoplasm; Female; Hydroxyurea; Kineti | 1976 |
[Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Topics: Agranulocytosis; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Life | 1976 |
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Lar | 1975 |
Management of Hodgkin's and non-Hodgkin's lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1975 |
Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Pos | 1976 |
Non-Hodgkin's lymphoma in children.
Topics: Adolescent; Central Nervous System; Child; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphom | 1976 |
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.
Topics: Cell Survival; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Ethacrynic Acid; Human | 1990 |
Active oxygen radicals produced by leukocytes of malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Electron Spin Resonan | 1990 |
[Malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1985 |
Hematologic malignancies: non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1986 |
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
Topics: Antineoplastic Agents; B-Lymphocytes; Bleomycin; Bone Marrow; Cell Line; Cell Separation; Cisplatin; | 1988 |
Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma.
Topics: Administration, Cutaneous; Age Factors; Aged; Female; Follow-Up Studies; Humans; Lymphoma; Male; Mec | 1989 |
[Secondary leukemia (AML) with TcR beta rearrangement].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Female; Gene Rearra | 1989 |
ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 1985 |
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1989 |
Side effects and emotional distress during cancer chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxor | 1989 |
Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; D | 1987 |
The contribution of alkylation to the activity of quinone antitumor agents.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Base Sequence; Cell Survival; Chemical Phenomena; | 1986 |
Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Hodgkin Disease; Humans; Immun | 1986 |
Purpura fulminans in pneumococcal sepsis.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Fema | 1986 |
Composite lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans | 1986 |
The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Female; Hod | 1985 |
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Current status and new vistas in combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Fertil | 1985 |
Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; | 1985 |
Fertility in young men and women after treatment for lymphoma: a study of a population.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fertility; Follicle Stimu | 1985 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Prot | 1985 |
Management of malignant lymphomas: a practical and philosophical approach.
Topics: Bleomycin; Cyclophosphamide; Hodgkin Disease; Hospitals, Special; Humans; Laparotomy; Lymphoma; Mech | 1973 |
Tissue NAD levels and the response to irradiation of cytotoxic drugs.
Topics: Animals; beta-Aminoethyl Isothiourea; Cysteamine; Female; Lymphoma; Male; Mechlorethamine; Mice; NAD | 1970 |
Alkaline sucrose sedimentation studies of DNA from P388F lymphoma cells treated with disfunctional alkylating agents.
Topics: Alkanesulfonates; Carbon Isotopes; Cells, Cultured; Centrifugation, Density Gradient; Culture Media; | 1973 |
The use of counter-current distribution to examine the effect of damaging agents on DNA.
Topics: Alkylating Agents; Animals; Carbon Radioisotopes; Cell Line; Chromatography; Countercurrent Distribu | 1973 |
The induction of thymidine- and IUdR-resistant variants in P388 mouse lymphoma cells by x-rays, UV and mono- and bi-functional alkylating agents.
Topics: Alkylating Agents; Animals; Cell Line; Cells, Cultured; DNA Repair; DNA, Neoplasm; Dose-Response Rel | 1974 |
Mycosis fungoides lymphoma.
Topics: Administration, Topical; Antineoplastic Agents; Humans; Lymphoma; Mechlorethamine; Mycosis Fungoides | 1974 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Management of patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Ly | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Topics: Alkylating Agents; Animals; Cell Line; Cell Survival; Chlorambucil; Clone Cells; Cyclophosphamide; F | 1972 |
Combination chemotherapy for patients with malignant lymphoma.
Topics: Antineoplastic Agents; Drug Combinations; Follow-Up Studies; Humans; Lymphoma; Mechlorethamine; Pred | 1972 |
An improved method for measuring cross-links in the DNA of mammalian cells: the effect of nitrogen mustard.
Topics: Animals; Cell Line; Centrifugation, Density Gradient; Cesium; Chemical Phenomena; Chemistry; DNA; Ly | 1973 |
Combination chemotherapy in malignant disease.
Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Fem | 1971 |
Treatment and results in malignant lymphoma.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lymphoma; | 1971 |
[Results and current biological bases of therapy of malignant hemoreticulopathies].
Topics: Antineoplastic Agents; Chlorambucil; Cortisone; Cyclophosphamide; Humans; Hydrazines; Leukemia; Lymp | 1971 |
Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
Topics: Agranulocytosis; Alkylating Agents; Bone Marrow Cells; Bone Marrow Examination; Cyclophosphamide; En | 1972 |
Sensitivity to nitrogen mustard as a function of transport activity and proliferative rate in L5178Y lymphoblasts.
Topics: Animals; Biological Transport; Carbon Isotopes; Cell Division; Cell Line; Cells, Cultured; Choline; | 1971 |
Recent advances in chemotherapy of lymphoma.
Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1967 |
Chemotherapy of the lymphomas.
Topics: Antimetabolites; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Mechloreth | 1970 |
Cutaneous lymphoma complicating basal cell carcinoma of the face.
Topics: Carcinoma, Basal Cell; Chemotherapy, Cancer, Regional Perfusion; Facial Neoplasms; Humans; Lymphoma; | 1970 |
[Chemotherapy of malignant lymphomas].
Topics: Adrenal Cortex Hormones; Amines; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines | 1970 |
[Treatment of malignant reticulohemopathies with limewashing using mechlorethamin].
Topics: Adult; Aged; Female; Humans; Lymphoma; Male; Mechlorethamine; Middle Aged; Mycosis Fungoides; Sarcom | 1970 |
[Diagnosis and treatment of malignant lymphomas].
Topics: Adrenal Cortex Hormones; Cyclophosphamide; Humans; Lymphoma; Mechlorethamine; Triaziquone; Vinblasti | 1967 |
Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
Topics: Adult; Antineoplastic Agents; Busulfan; Chlorambucil; Hodgkin Disease; Humans; Leukemia; Lymphoma; M | 1968 |